“Complex Regional Pain Syndrome Market” report has been recently added to DelveInsight
The Complex Regional Pain Syndrome Market report on gives adjusted data which has the mix of the past, current and future information that assists with understanding the Global Complex Regional Pain Syndrome Market better. As such, it is a thorough rundown of the multitude of significant variables that are identified with expanding request development with regards to the market across the world. The report likewise gives subtleties of future prospects which have the most recent patterns that are to be found in the coming a long time in this focused on Complex Regional Pain Syndrome Market
About Complex Regional Pain Syndrome Disease
Complex regional pain syndrome (CRPS) is defined as a “painful syndrome, which includes regional pain, sensory changes (e.g. allodynia), abnormalities of temperature, abnormal sudomotor activity, edema and an abnormal skin color that occurs after an initiating noxious event such as trauma etc.” CRPS may develop after major trauma, surgery, or minor injury, and progresses with a variable course that ranges from self-limiting, mild symptomatology to chronic disease.
Request for free sample copy of CRPS market report- https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-market
CRPS Geography Covered
Complex Regional Pain Syndrome Key Player
Global Complex Regional Pain Syndrome Market
As per the Classification of Chronic Pain (Merskey and Bogduk 2011) of the IASP and fourth edition of CRPS guidelines, “CRPS-I is a syndrome characterized by a continuing (spontaneous and/or evoked) regional pain that is seemingly disproportionate in time or degree to the usual course of pain after trauma or another lesion. The pain is regional (not in a specific nerve territory or dermatome) and usually has a distal predominance of abnormal sensory, motor, sudomotor, vasomotor/edema and/or trophic findings. The syndrome shows variable progression over time. CRPS-I occurs after any form of trauma, particularly a fracture or soft tissue lesion. CRPS-II occurs after nerve damage.”
Complex Regional Pain Syndrome Treatment Market
Currently, the treatment of CRPS is restricted to palliative care and symptom-based interventions such as Non-opioid analgesics (Paracetamol, NSAIDs, Nefopam etc.), Weak opioid analgesics (Tramadol, Codeine/Acetaminophen, Opium/PCM etc.), Strong opioid analgesics, Co-analgesics (Corticosteroids, Antiepileptics, Antidepressants, Tricyclic Antidepressants, SNRIs, Bisphosphonate, IV Bisphosphonate, Calcitonin, Ketamine etc.), Local treatment (Joint infusion of corticosteroids, Lidocaine cream, Lidocaine patch, Capsaicin, NSAIDs etc.) and others (including Physiotherapy, surgery, Psychological interventions etc.). Currently, Neridronate is the only first line drug that has showed its efficacy in CRPS patients and available in the Italy market. It is the only therapy approved for the treatment of CRPS in Italy (Abiogen Pharma).
Complex Regional Pain Syndrome Market: Report Highlights
Following is the table of content of CRPS Market Report
1. Key Insights
2. Executive Summary of Complex Regional Pain Syndrome (CRPS)
3. SWOT Analysis
4. Epidemiology and Market Forecast Flow
5. Complex Regional Pain Syndrome (CRPS): Market Overview at a Glance
6. Complex Regional Pain Syndrome (CRPS): Disease Background and Overview
7. Epidemiology and Patient Population
8. Treatment and Management of CRPS
8.1. Treatment Guidelines
9. Unmet Needs
10. Patient Journey
11. Key Endpoints in CRPS Clinical Trials
12. Emerging Therapies
13. CRPS: Seven Major Market Analysis
14. Market Access and Reimbursement
15. Market Drivers
16. Market Barriers
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
Complex Regional Pain Syndrome Market: Important Reasons to buy
Related Report
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash Bhardwaj Email: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 Country: United StatesWebsite: www.delveinsight.com/